Pain Relieving Burn Gel is a Topical Gel in the Human Otc Drug category. It is labeled and distributed by Yuyao Jessie Commodity Co.,ltd.. The primary component is Lidocaine.
Product ID | 51414-909_7eafa811-75c3-077f-e053-2991aa0a8af0 |
NDC | 51414-909 |
Product Type | Human Otc Drug |
Proprietary Name | Pain Relieving Burn Gel |
Generic Name | Burn Gel |
Dosage Form | Gel |
Route of Administration | TOPICAL |
Marketing Start Date | 2019-01-01 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part346 |
Labeler Name | Yuyao Jessie Commodity Co.,Ltd. |
Substance Name | LIDOCAINE |
Active Ingredient Strength | 2 g/100g |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-01-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-01 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-01 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Marketing Category | OTC monograph final |
Application Number | part346 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-04 |
Ingredient | Strength |
---|---|
LIDOCAINE | 2 g/100g |
SPL SET ID: | 7eafa811-75c1-077f-e053-2991aa0a8af0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
51414-909 | Pain Relieving Burn Gel | Burn Gel |
71105-096 | Rediburn Burn Gel Skin Protectant | Burn Gel |